News
BSX
43.92
-1.70%
-0.76
FDA Classifies Boston Scientific's Recall Of Imager II Angiographic Catheters As Class I Due To Potential Catheter Tip Degradation And Detachment Risk
Benzinga · 2d ago
Boston Scientific Price Target Cut to $48.00/Share From $50.00 by Wells Fargo
Dow Jones · 3d ago
Boston Scientific Is Maintained at Equal-Weight by Wells Fargo
Dow Jones · 3d ago
Wells Fargo Maintains Equal-Weight on Boston Scientific, Lowers Price Target to $48
Benzinga · 3d ago
Boston Scientific price target lowered to $48 from $50 at Wells Fargo
TipRanks · 4d ago
Boston Scientific (BSX) Could Be 27% Undervalued Following Earnings Growth Focus
Simply Wall St · 4d ago
Astrana is latest U.S. healthcare company to face acyberattack
Seeking Alpha · 4d ago
Boston Scientific Announces Retirement of MedSurg, Asia Pacific Chief
TipRanks · 5d ago
Is Software Recall Risk Altering The Investment Case For Boston Scientific Stock?
Simply Wall St · 5d ago
S&P 500 nears record level, but breadth shows signs of stress
Seeking Alpha · 5d ago
2 Value Stocks with Exciting Potential and 1 We Avoid
Barchart · 6d ago
Option traders moderately bearish in Boston Scientific with shares down 0.38%
TipRanks · 6d ago
Boston Scientific Price Target Cut to $65.00/Share From $85.00 by Oppenheimer
Dow Jones · 6d ago
Boston Scientific Is Maintained at Outperform by Oppenheimer
Dow Jones · 6d ago
Oppenheimer Maintains Outperform on Boston Scientific, Lowers Price Target to $65
Benzinga · 6d ago
Boston Scientific price target lowered to $65 from $85 at Oppenheimer
TipRanks · 6d ago
New Strong Sell Stocks for September 21st
NASDAQ · 09/21 10:45
Analysts Offer Insights on Healthcare Companies: Danaher (DHR), Argenx Se (ARGX) and Boston Scientific (BSX)
TipRanks · 09/21 10:30
Weekly Report: what happened at BSX last week (0914-0918)?
Weekly Report · 09/21 09:38
Boston Scientific (BSX) Stock Could Be A Bargain On Strong Cash Flow Views
Simply Wall St · 09/19 20:27
More
Webull provides a variety of real-time BSX stock news. You can receive the latest news about Boston Scien Cp through multiple platforms. This information may help you make smarter investment decisions.
About BSX
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology and vascular therapies (ICVT), watchman, cardiac rhythm management, and electrophysiology.